ClinicalTrials.Veeva

Menu

AntiCoagulation Tracking InterVention and Evaluation (ACTIVE)

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status

Withdrawn

Conditions

Atrial Flutter
Atrial Fibrillation
Anticoagulation
Stroke
Pulmonary Embolus/Emboli
Deep Vein Thrombosis
Hypercoagulability

Treatments

Other: Panel Management for Anticoagulation Therapy
Other: Usual Care

Study type

Interventional

Funder types

Other

Identifiers

NCT04059965
P0534218

Details and patient eligibility

About

Anticoagulants are a leading cause of acute injury from adverse drug events, leading to ~20,000 serious injuries reported to the Food and Drug Administration per year and more than 220,000 emergency department visits annually. Therefore, we propose to implement a health information technology (HIT) population management tool at two distinct anticoagulation clinics that will allow the care team to assign and track tasks essential for timely patient monitoring. We will examine its effect on anticoagulation management outcomes through a randomized trial, hypothesizing that such interventions can be effective as well as cost-effective strategies to improve patient safety in the context of anticoagulation management services.

Sex

All

Ages

18 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adults (age ≥18 years)
  • those prescribed an anticoagulation medication at Zuckerberg San Francisco General Hospital or University of California, San Francisco Health

Exclusion criteria

  • Minors (age<18)
  • those not prescribed anticoagulation medication at ZSFG or UCSF Health

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

0 participants in 2 patient groups

Intervention Arm
Experimental group
Description:
This cohort of patients will receive panel management through a customize software that integrates with the electronic health record
Treatment:
Other: Panel Management for Anticoagulation Therapy
Control Arm
Active Comparator group
Description:
This cohort of patients will receive usual care
Treatment:
Other: Usual Care

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems